Bioasis Technologies is dedicated to delivering hope to patients suffering with neurological diseases and disorders. The Company focuses on transporting medicines across the blood-brain barrier, providing a path to address previously untreatable diseases of the central nervous system. As a preclinical biopharmaceutical company, Bioasis needed to sharpen its core story, build awareness, grow its investor base and attract high-level employees.
Wyant Simboli worked closely with Bioasis’ senior management to uncover the company’s core story and re-design its brand identity. We developed a new website and produced videos to clearly explain the problem posed by the blood-brain-barrier and the potential of the Company’s xB3 platform to deliver hope to patients suffering with neurological disease.